Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2‐year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry

PURPOSE: To report the 24‐month outcomes of vascular endothelial growth factor (VEGF) inhibitors for myopic choroidal neovascularization (mCNV) in predominantly Caucasian eyes in routine clinical practice. METHODS: Retrospective analysis of treatment‐naïve eyes starting intravitreal injection of VEG...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabrielle, Pierre‐Henry, Nguyen, Vuong, Creuzot‐Garcher, Catherine, Miguel, Lucia, Alforja, Socorro, Sararols, Laura, Casaroli‐Marano, Ricardo P., Zarranz‐Ventura, Javier, Gillies, Mark, Arnold, Jennifer, Barthelmes, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290852/
https://www.ncbi.nlm.nih.gov/pubmed/33960115
http://dx.doi.org/10.1111/aos.14893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290852/
https://www.ncbi.nlm.nih.gov/pubmed/33960115
http://dx.doi.org/10.1111/aos.14893

Ejemplares similares